The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs)
- 31 March 1997
- Vol. 79 (2-3) , 95-99
- https://doi.org/10.1016/s0300-9084(97)81497-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995
- The effects of fibrates on lipoprotein and hemostatic coronary risk factorsAtherosclerosis, 1994
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.Journal of Clinical Investigation, 1993
- Postprandial lipemia, fenofibrate and coronary artery diseaseAtherosclerosis, 1990
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administrationAtherosclerosis, 1989
- Detection and characterization of the heterozygote state for lipoprotein lipase deficiency.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.Journal of Clinical Investigation, 1986